Skip to main content

Peer Review reports

From: Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil

Original Submission
14 Oct 2024 Submitted Original manuscript
4 Nov 2024 Reviewed Reviewer Report - Ikenna I. Nnabugwu
15 Nov 2024 Reviewed Reviewer Report
16 Nov 2024 Reviewed Reviewer Report
13 Dec 2024 Author responded Author comments - Vanessa Cortes
Resubmission - Version 2
13 Dec 2024 Submitted Manuscript version 2
17 Dec 2024 Author responded Author comments - Vanessa Cortes
Resubmission - Version 3
17 Dec 2024 Submitted Manuscript version 3
8 Jan 2025 Author responded Author comments - Vanessa Cortes
Resubmission - Version 4
8 Jan 2025 Submitted Manuscript version 4
17 Jan 2025 Author responded Author comments - Vanessa Cortes
Resubmission - Version 5
17 Jan 2025 Submitted Manuscript version 5
Publishing
23 Jan 2025 Editorially accepted
31 Jan 2025 Article published 10.1186/s12894-025-01701-1

You can find further information about peer review here.

Back to article page